n e w s a n d v i e w s
These results indicate that left lateral prefrontal cortex has a critical role in people's ability to choose larger, delayed rewards over smaller, immediate ones. They show that a brain mechanism exists that leads people to give greater weight to delayed outcomes and where this mechanism is instantiated neurally. The obvious next question is how. What exactly is left lateral prefrontal cortex doing?
Although they do not draw firm conclusions on this question, Figner and colleagues 1 seem to favor a 'classical self-control' mechanism. This proposal builds on previous work demonstrating that medial prefrontal cortex, and possibly other regions, compute the subjective value of different options during decisionmaking 5, 12, 13 . This proposal adds a second self-control mechanism, whereby lateral prefrontal cortex can interrupt or override the reward valuations computed elsewhere in the brain, such that delayed rewards that would otherwise be valued lower than immediate ones are still ultimately selected. In this case, lateral prefrontal cortex would have a direct effect on choices and there would be a disjunction between valuation and choice that would explain the differential effects of TMS on attractiveness judgments and choices.
Other models are consistent with these data, however. For example, lateral prefrontal cortex might act to modulate or provide input to, rather than override, valuations computed elsewhere in the brain. A similar proposal was made recently in an fMRI study of dieters resisting good-tasting, but unhealthy, foods 12 . In this case, the effects of lateral prefrontal cortex on choice would be indirect and would be completely mediated by changes in value signals in other brain regions. This model could account for the dissociations in the TMS data if the lateral prefrontal cortex only comes online during choices involving immediate rewards. Furthermore, the modulatory role proposed for prefrontal activity in this model is similar in form to that proposed for other domains of cognition 14 .
In either case, an important goal for future work is to understand the specific computations being performed in lateral prefrontal cortex. What causes lateral prefrontal cortex to be engaged during decision-making, why might it be engaged more in some decisions than in others and how does this computation affect processing in other brain regions? Previous work suggests several possibilities to be explored, including whether prefrontal cortex encodes behavioral goals, task contexts or decision rules. One speculation along these lines is that prefrontal cortex computes social costs. Being impatient and choosing the immediate reward might implicitly be regarded as a negative social signal, in the same way that accepting inequitable outcomes proposed by social partners, being taken advantage of, is a negative cue 15 .
One reason a computational explanation is so important is that this level of understanding is most likely to inform translational efforts. From clinics to financial advice centers, there are ongoing efforts to promote more patient decisions, future-oriented choices that give greater weight to long-term, delayed outcomes. Public health campaigns try to persuade people to eat better, exercise and avoid smoking or using drugs. Financial advisors encourage people to save more for retirement and to avoid loans that are beyond their means. These practical efforts would be informed by an understanding of the computational mechanisms that are involved when people choose delayed rewards over immediate ones. On this front, the study of Figner and colleagues 1 provides an important step forward. By understanding the influence of lateral prefrontal cortex, perhaps we could all get a little more patience.
Anxious interactions

Javier González-Maeso
The molecular mechanisms responsible for anxiety remain largely unresolved. A study in this issue finds that an interaction between receptors for a hormone and a neurotransmitter regulates anxiety.
Fear is an important evolutionary force. Animals need to distinguish between different environmental factors and respond to aversive situations in a way that maximizes their chance of survival and that of their offspring. Normally, a fearful state protects us from potential danger or threat. In humans, however, certain environmental cues, such as being asked to give a speech in front of others, are able to trigger lasting behavioral changes that can be converted into maladaptive, pathological fear and anxiety. Giving a speech in front of an audience typically generates states of fear and normal anxiety, but those disappear once the talk has been completed. People with anxiety disorder 1 , on the contrary, find it almost impossible to accomplish this task and have pathological anxiety states in response to even the suggestion of being invited to give an oral presentation. Unfortunately, we don't have a clear understanding of why this happens. The absence of clear pathological alterations in the brain of individuals with psychiatric disorders, such as anxiety and depression, is currently one of the most challenging aspects of neuroscience research. The quest to uncover these changes has led to the development of a multitude of hypotheses, many of which are focused on a single hormone or neurotransmitter. In this issue, Magalhaes et al. 2 connect two signaling systems that have been separately implicated in anxiety behaviors, finding that the two interact to induce anxiety.
nature neuroscience volume 13 | number 5 | may 2010 n e w s a n d v i e w s Both the neurotransmitter serotonin and the hormone corticotropin-releasing factor (CRF) have been implicated in the molecular underpinnings of anxiety disorders. Serotonin modulates behavioral responses to novelty and threat 1 . Antidepressants with anxiolytic properties, such as mirtazapine, act, at least in part, by blocking the activation of the serotonin 5-HT 2A receptor 3 , and mice that lack a functional 5-HT 2A receptor 4 have reduced anxietylike behaviors. These observations suggest that serotonin, and particularly the 5-HT 2A receptor, is important in the etiology of anxiety and in the response to anxiolytic drugs. When CRF was first discovered in the hypothalamus 5 , its modulation of the behavioral responses to stress was thought to be restricted to the regulation of hormone secretion by the hypothalamic-pituitary-adrenal axis. However, CRF receptors are widely expressed in different brain regions and regulate physiological responses in both anxiety states and behavioral mechanisms of defense 6 . Drugs that block the activation of CRF 1 receptor act as anxiolytic agents 7 .
Both 5-HT 2A and CRF 1 receptors belong to the superfamily of G protein-coupled receptors (GPCRs) 8 , also termed seven-transmembrane receptors. This structural class of membrane proteins is the target of approximately 60% of the current therapeutic drugs in the market, including more than a fourth of the 100 topselling drugs. A central question in biology today is how the cell integrates information from multiple receptors to achieve the appropriate response. Magalhaes et al. 2 wondered whether a functional link exists between 5-HT 2A and CRF 1 receptors that might affect anxiety-like behaviors in mice. The 5-HT 2A receptor is typically coupled to Gq/11 proteins, which leads to the hydrolysis of a phospholipid component at the plasma membrane followed by the generation of diacylglycerol and inositol triphosphate (IP3). Magalhaes and colleagues 2 found that activation of CRF 1 receptor potentiates the IP3 formation in response to 5-HT 2A/2C receptor stimulation. This effect is not observed with the activation of the closely related CRF 2 receptor, indicating that the functional crosstalk between 5-HT 2A/2C and CRF 1 receptors is specific. In unstimulated cells, the rate of GPCR endocytosis from the plasma membrane into intracellular vesicles is relatively slow and this rate is markedly increased by agonist activation 9 . However, and in contrast with what is observed for most of the GPCR subtypes, the 5-HT 2A/2C receptor has a high rate of basal internalization 10 . Magalhaes et al. 2 found that activation of CRF 1 receptor markedly increases its rate of endocytosis and that 5-HT 2A colocalizes with CRF 1 in the same intracellular membrane compartments. Once the receptors have been internalized, they can either be recycled back to the plasma membrane or directed to lysosomes for degradation 11 . Magalhaes and colleagues' findings 2 suggest that activation of CRF 1 receptor increases the expression of 5-HT 2A receptor at the cell surface and that inhibition of rapid recycling of receptors from early endosomes to the plasma membrane blocks the potentiation of 5-HT 2A receptor-dependent signaling by CRF 1 receptor activation. The intracellular tails of the two receptors are necessary for this functional interaction 2 , as deletion of the last three amino acids results in the reduction of the effects of CRF 1 activation on 5-HT 2A signaling and cell surface expression (Fig. 1) .
Finally, Magalhaes et al. 2 found a behavioral interaction between 5-HT 2A and CRF 1 receptors in mouse models of anxiety disorders. Although they often occur together, anxiety and major depression are considered to be two distinct psychiatric disorders. An emerging approach to better understand the mechanisms underlying depression and anxiety is the development of mouse behavioral procedures that model the symptoms of only one of the two disorders 12 . Mouse models of anxiety disorder include the open field exploration test and elevated plus-maze 13 . The open field is a large square chamber that allows the mouse to choose between the unprotected center of the arena and the safety of the corners. Mice that spend more time exploring the novelty of the center area demonstrate less anxiety-like behavior. The elevated plus-maze has two unprotected arms (open without sidewalls) and two protected arms (closed with sidewalls). Mice tend to avoid the open areas, especially when they are brightly between 5-HT 2A and CRF 1 receptors has been abolished. Before the early 2000s, GPCRs were believed to be expressed at the cell membrane as individual monomeric units. A number of findings in the last decade support the hypothesis that GPCRs are expressed as homo-and hetero-dimers or even higher-order oligomers that modulate their function and ligand pharmacology 14 , yet the transmembrane domains are generally responsible for this type of receptor complex formation. Several studies have also revealed that many intracellular soluble proteins interact directly or indirectly, via scaffolding proteins, with intracellular C-terminal tails of GPCRs and control their trafficking and signaling 15 . A new mechanism of interaction between two membrane receptors that requires their intracellular tails and affects cell surface expression opens a line of research to explore not only the biophysical properties of that heteromeric protein complex, but also the molecular explanation for anxiety.
lit. An increase in open arm activity reflects less anxiety-like behavior. The authors 2 
Degeneration keeps axons on the straight and narrow
Bruce D Carter
Axon degeneration in the adult brain is usually pathological, but a new study finds that mis-sprouting cholinergic axons in the healthy mouse brain are eliminated by a degenerative process that is triggered by myelin via p75NTR.
Axonal degeneration and pruning is a normal process in the developing nervous system and is required for establishing proper connectivity. Such degeneration shares many characteristics with apoptosis and often accompanies neuronal cell death but also occurs independently in a localized manner that does not disrupt the overall integrity of the neuron. In the adult nervous system, abnormal axonal degeneration contributes to diabetic neuropathy, multiple sclerosis and Alzheimer's disease. However, it has been unclear whether there is any physiologically normal axonal degeneration in the healthy adult. In this issue, Park et al. 1 describe active axonal breakdown in the adult mammalian nervous system, suggesting a mechanism for the elimination of aberrant collaterals that could disrupt the normal circuitry. Furthermore, they find that myelin contact and the p75 neurotrophin receptor (p75NTR) are signal triggers for local degeneration (Fig. 1) .
The p75NTR is well known for its ability to signal programmed cell death in the developing nervous system and in response to certain injuries 2 . It is also a component of the receptor complex that inhibits axonal growth in response to the myelin proteins Nogo, myelinassociated glycoprotein and oligodendrocyte myelin glycoprotein 3 . These inhibitory proteins bind to a membrane-tethered protein, Nogo receptor (NgR), which activates p75NTR, causing growth cone collapse and the inhibition of axonal growth. The suppression of axonal growth by myelin proteins accounts in part for the inability of central nerves to regenerate following injuries such as spinal cord damage or ischemia. However, it is unlikely that this system evolved for the sole purpose of preventing nerve regeneration after injury, thus raising the question as to its normal physiological function.
Several recent findings suggest that myelin and p75NTR are involved in inhibitory signaling in the normal refinement of neuronal circuitry during development. Mice lacking NgR have a prolonged period of plasticity in the visual cortex 4 . The cessation of the plastic period occurs as cortical myelination is completed and is associated with the restriction of axonal remodeling. Hence, this finding indicates that myelin inhibitory proteins may terminate plasticity by preventing axons from extending collaterals and making new connections.
Similarly, local activation of p75NTR by neurotrophins during development can cause processes to retract or degenerate. Activation of p75NTR causes the retraction of presynaptic terminals in motor neurons cultured with muscle cells, but the cell soma remains intact 5 . Previous work 6 has shown that selective activation of p75NTR by brain-derived neurotrophic factor (BDNF) on the distal axons of sympathetic neurons causes the axons to degenerate without affecting the cell body, which is maintained in nerve growth factor (NGF) to promote survival. Furthermore, there is excess sympathetic innervation in the eye 6 and pineal gland 7 in Ngfr (p75ntr) −/− mice, suggesting that these mice fail to properly prune their axons during development. Thus, activation of p75NTR can suppress axonal growth and actively promote local fiber degeneration.
To investigate a potential role for p75NTR in restricting axonal growth or promoting degeneration in response to myelin in the healthy adult nervous system, Park et al. 1 
examined cholinergic neuron projections
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